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Answers
1. Reflux nephropathy could possibly explain the hyper-
tension, but hypokalemia is unlikely in patients with
reflux nephropathy.
2. A monogenic form of hypertension should be exclud-
ed. Liddle syndrome, apparent mineralocorticoid
excess, or glucocorticoid-remediable aldosteronism
(GRA) would account for the hypertension and hypo-
kalemia.
3. Increased urinary oxo-steroids or an abnormal ratio
of urine oxo-steroids to cortisol would confirm the
diagnosis of GRA. An abnormal ratio of urine cortisol
to cortisone would confirm a diagnosis of the syn-
drome of apparent mineralocorticoid excess.
4. The best treatment for GRA is oral dexamethasone and
spironolactone.
Commentary
This patient presents with severe hypertension and hypo-
kalemia. She also has a history of reflux nephropathy.
Reflux nephropathy has been associated with abnormal-
ities of the renin-angiotensin-aldosterone system [1, 2],
but rarely causes severe hypertension [3]. In patients with
duplex ureters and vesicoureteral reflux, the lower kidney
poles are often dysplastic from the start, and these defects
are not often associated with high blood pressure. Reflux
nephropathy could therefore not be the sole cause of
hypertension in our patient, unless associated with a renal
artery stenosis. Given the normal findings on both duplex
Doppler sonography and 123I-Hippuran renal scan, renal
artery stenosis was unlikely. The strong family history
suggests the presence of a monogenic form of hyperten-
sion with hypokalemia. GRA is inherited as an autosomal
dominant trait, and is associated with a high incidence of
subarachnoid hemorrhages. GRA is due to gene chimer-
ism. The hybrid, or chimeric gene, combines the 50
promoter sequence of the 11b-hydroxylase gene fused to
the more-distal 30 aldosterone synthase coding sequence.
As a result, aldosterone synthase is ectopically expressed
in the cortisol-producing zone of adrenal cortex under the
regulation of adrenocorticotropic hormone (ACTH) [4].
Hypertension is often early and may be of sufficient
severity to result in death, commonly from intracerebral
or subarachnoid hemorrhages [5]. The diagnosis is made
by demonstrating the presence of an excessive production
of 18-hydroxy- and 18-oxo-cortisol, as a result of aberrant
expression of aldosterone synthase activity in the zona
fasciculata, where cortisol is a substrate.
Apparent mineralocorticoid syndrome also causes
severe hypertension with hypokalemia. It is secondary
to the absence or inhibition of the 11-b-steroid dehydro-
genase. This enzyme converts the hormonally active
cortisol, which has a strong mineralocorticoid action, to
the less active cortisone [6]. Liddle syndrome is caused by
hyperactivity of the epithelial sodium channel (ENaC)
secondary to mutations in the subunits [7]. This is
transmitted as an autosomal dominant disorder, with early
penetrance. Hypertension is severe, but hypokalemia is
less marked than in GRA or apparent mineralocorticoid
excess (Table 1). Measurements of plasma renin activity,
plasma aldosterone, urinary 18-oxo-steroids, and urinary
cortisol/cortisone ratio can lead to the correct diagnosis.
Our patient and her father had a suppressed plasma renin
activity (daughter 0.09 ng/ml per hour, normal 0.45–3.70,
father <0.05 ng/ml per hour, normal 0.2–2.0) with
elevated plasma aldosterone (daughter 320 pg/ml, normal
29–76, father 142 pg/ml, normal 29-76) (Professor J.
Nussberger, personal communication; [8]). Although our
patient had a normal urinary steroid profile, her father had
an increased 18-oxo-steroid excretion (643 mg/day, nor-
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mal 6–410). Treatment with 0.5 mg/day oral dexameth-
asone and oral spironolactone 25 mg twice daily normal-
ized her blood pressure within 2 weeks. More than a year
later, she is still normotensive (110/70 to 120/80 mmHg)
on the same drug treatment. Dexamethasone inhibits
ACTH secretion (and secondary aldosterone production),
whereas spironolactone blocks the aldosterone receptors
in the distal tubules and collecting ducts (and decreases
sodium reabsorption). The father declined dexamethasone
therapy, and is still hypertensive on a b-blocker and an
angiotensin converting enzyme inhibitor. Even without
genetic analysis, we feel that the striking family history,
biochemical findings, and response to specific therapy
confirm the diagnosis of GRA in that family.
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Table 1 Features of glucocorticoid-remediable aldosteronism
(GRA), apparent mineralocorticoid excess (AME), and Liddle
syndrome (AD autosomal dominant, AR autosomal recessive)
GRA AME Liddle
Hypertension 3+ 3+ 3+
Genetics AD AR AD
Hypokalemia 3+ 3+ +
Salt sensitivity 3+ 2+ 3+
Plasma renin activity # # #
Plasma aldosterone " # #
Urinary cortisol/cortisone ratio Normal " Normal
Urinary 18-oxo-steroids " Absent Absent
Response to amiloride Yes Yes Yes
Response to spironolactone Yes No/poor No
Response to dexamethasone Yes Yes No
699
